Zurich Cantonal Bank
AVDL

Zurich Cantonal Bank’s Avadel Pharmaceuticals AVDL Stock Holding History

Zurich Cantonal Bank’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,707
Closed -$813K – 2656
2025
Q4 		$813K Buy
+37,707
New +$732K ﹤0.01% 1465

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Zurich Cantonal Bank's AVDL Position: Q4 2025 in Review

Zurich Cantonal Bank sold out of Avadel Pharmaceuticals (AVDL) in Q4 2025, closing a stake of 37,707 shares — an estimated $732K sold.

Zurich Cantonal Bank first reported a position in AVDL in Q1 2022 and held it in 14 quarters. The position peaked at $576K in Q3 2025. 207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

  • Zurich Cantonal Bank reported no remaining Avadel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 37,707 Avadel Pharmaceuticals shares in Q4 2025, an estimated $732K.
  • Zurich Cantonal Bank first reported a position in Avadel Pharmaceuticals in Q1 2022 and held it in 14 quarters.
  • Zurich Cantonal Bank's Avadel Pharmaceuticals position peaked at $576K in Q3 2025.
  • 207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on Zurich Cantonal Bank's 13F filing for Q4 2025, filed 27 Jan 2026.